[Heavyweight] The results of the centralized procurement of the Yangtze River Delta Alliance were announced, and the industry leaders responded positively, improving quality and reducing prices for the benefit of the people!

On March 17, the results of centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions were officially announced! The Yangtze River Delta Alliance with Shanghai, Zhejiang and Anhui as the main body "wins its first battle"
.

Reducing the price of good medicines, reducing the pressure of medical insurance payment, and providing medical care for the common people are the eternal themes of the centralized procurement work.
While consolidating the effectiveness of the national centralized procurement work, the Yangtze River Delta Alliance has steadily explored a new model of inter-provincial centralized procurement
.

Throughout this centralized procurement, the new rules have thoroughly implemented the guidance proposed by the state to " adhere to volume-based procurement, ensure quality, promote innovation-driven, stabilize supply, ensure clinical use, and set bidding rules for specific varieties and competitive landscapes ".

While consolidating the effectiveness of the national centralized procurement work, the Yangtze River Delta Alliance has steadily explored a new mode of inter-provincial centralized procurement

There are 47 drugs to be selected in Anhui Province and Zhejiang Province , 38 drugs to be selected in Shanghai , and the missing varieties are atorvastatin, rosuvastatin, entecavir, olanzapine, cefuroxime axetil, risperidone , gefitinib, tenofovir disoproxil fumarate and montmorillonite powder .

Leading enterprises in the industry actively responded to the call of the alliance to reduce the price as much as possible while ensuring the winning of the drug bid and the reasonable profits of the enterprise

According to the public information of Shanghai Sunshine Pharmaceutical Purchasing Network, although the varieties and specifications of the Yangtze River Delta Alliance are the same, the packaging will be flexibly adjusted according to needs.
For example, rosuvastatin won the bid in Anhui Province and Zhejiang Province.
Due to different packaging, Nanjing Chia Tai Tian Qing won the bid in Anhui Province at a price of 3.
76 yuan/box (14 packs), while Zhejiang Jingxin Pharmaceutical Co.
, Ltd.
signed a contract with Zhejiang Province at a price of 5.
5 yuan/box (28 packs), which fully reflects the centralized procurement of the Yangtze River Delta Alliance .
The scientific spirit of adjusting measures to local conditions and the pragmatic attitude of seeking truth from facts
.

It fully reflects the scientific spirit of the Yangtze River Delta Alliance's centralized procurement and the pragmatic attitude of seeking truth from facts
.

List of drugs to be selected in Anhui Province

List of drugs to be selected in Zhejiang Province

List of drugs to be selected in Shanghai

Chen Jinfu, deputy director of the National Medical Security Administration, once pointed out that the most important thing in the centralized procurement work is the rules, which not only need to meet the product quality requirements and clinical needs, but also effectively allow enterprises and patients to share the results of the reform
.

It is impossible for the country to collect all varieties.

In this centralized procurement work, the Yangtze River Delta Alliance has continued the basic policy of the national centralized procurement.
Under the macro background of accelerating the national centralized procurement variety, expanding the coverage, continuing to increase efficiency, and expanding the benefits of the common people, the "comprehensive evaluation" has been introduced.
Indicator system", which is regarded by the industry as the "wind vane" of regional alliance centralized procurement
.

The Yangtze River Delta Alliance has a clear-cut attitude to encourage innovation.
Through a series of measures, it helps enterprises to rapidly increase their volume, accelerate the return of funds, improve their drug research and development capabilities, promote the survival of the fittest, realize the quality improvement and innovation of enterprises, and promote the development of innovative drugs in China
.

In addition, this centralized procurement calculates the score through the comprehensive evaluation of the two dimensions of drugs and enterprises, which strengthens the monitoring of drug quality, ensures the safety of new drugs, eliminates the possibility of corporate defaults from the system, and protects the well-being of the people.

Centralized procurement with volume has been with the industry for many years, and has achieved phased results in institutional reform and pharmaceutical industry governance, promoting the construction of a drug supply guarantee system under the new situation
.

The centralized and volume-based procurement led by medical insurance and actively participated by medical institutions will help to rationally optimize the drug supply guarantee and use structure of public hospitals, guide clinical drug use to the goal of rational drug use, and pay attention to the comprehensive consideration of drug quality, efficacy and cost-effectiveness.

The centralized and volume-based procurement led by medical insurance and actively participated by medical institutions will help rationally optimize the drug supply guarantee and use structure of public hospitals, and guide clinical drug use to the goal of rational drug use.